跳至主要内容
临床试验/EUCTR2014-000476-26-NL
EUCTR2014-000476-26-NL进行中(未招募)1 期

Dynamics of Androgen Receptor genomics and transcriptomics after neoadjuvant androgen ablation (DARANA) - Dynamics of Androgen Receptor after neoadjuvant androgen ablation

etherlands Cancer Institute0 个研究点目标入组 50 人开始时间: 2015年2月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • 1.Men over 18 years of age.
  • 2.clinically non-metastasized prostate cancer, tumor that can be imaged (TRUS or MRI) in order to allow for accurate preoperative biopsies.
  • 3.Gleason score 7-10
  • 4.written informed consent
  • 5.WHO performance 0-1
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 25
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 25

排除标准

  • 1.A history of seizures
  • 2.Clinically nodal metastases
  • 3.Prostatitis or urinary tract infection
  • Androgen ablative therapy within 6 weeks of inclusion (including 5 alpha-reductase inhibitors)

研究者

发起方
etherlands Cancer Institute

相似试验